ask="2.95"
ask_size="200"
average_daily_volume="657451"
bid="1.11"
bid_size="1000"
book_value="1.07"
change="-0.03"
change_from_200_day_moving_average="-1.05"
change_from_50_day_moving_average="-0.13"
change_from_52_week_high="-4.31"
change_From_52_week_low="0.50"
change_in_percent="-2.01%"
close="1.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.01"
ebitda="-16.58M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.28"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.50"
high_52_weeks="5.77"
last_trade_date="1/10/2017"
last_trade_price="1.46"
last_trade_size="106"
last_trade_time="4:00pm"
low="1.45"
low_52_weeks="0.96"
market_capitalization="17.07M"
moving_average_200_day="2.51"
moving_average_50_day="1.59"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.48"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.92%"
percent_change_from_50_day_moving_average="-7.93%"
percent_change_from_52_week_high="-74.69%"
percent_change_from_52_week_low="+52.08%"
previous_close="1.49"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.40"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.01"
stock_exchange="NCM"
symbol="PZRX"
volume="14221"
weeks_range_52="0.96 - 5.77"
